Drug · DIN 02274000
DIFFERIN XP
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since July 19, 2007; first marketed July 19, 2007.
- Drug Identification Number (DIN)
- 02274000
- Company (DIN owner)
- Galderma Canada Inc.Toronto, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Gel
- Route
- Topical
- Therapeutic class (ATC)
- Adapalene D10AD03
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| ADAPALENE | 0.3 % |
Notices of Compliance
Health Canada approvals that name this DIN.
- December 20, 2005: NOC 7664Supplement to a New Drug Submission (SNDS) · Provides for a new strength